1877 — Shanghai Junshi Biosciences Co Cashflow Statement
0.000.00%
- HK$21.46bn
- HK$21.92bn
- CNY1.95bn
Annual cashflow statement for Shanghai Junshi Biosciences Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | CAS | CAS | CAS | CAS | CAS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | -795 | -1,256 | -1,452 | -1,463 | -1,459 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | -1,456 | -605 | -1,776 | -2,005 | -1,434 |
Capital Expenditures | -580 | -902 | -394 | -833 | -691 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -160 | -1,016 | -43.3 | -101 | -202 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -740 | -1,918 | -437 | -933 | -893 |
Financing Cash Flow Items | 4,484 | 2,976 | 3,906 | 254 | -35.8 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 4,414 | 2,666 | 4,613 | 712 | 1,023 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 2,171 | 120 | 2,492 | -2,219 | -1,291 |